Core Laboratories (CLB) -2% in Monday''s trading after Morgan Stanley downgrades shares to Underweight from Equal Weight with a $20 price target, while Helmerich &Payne (HP)
Core Laboratories has just come through an awful quarter and its shares are reflective of that. See why I rate CLB stock a speculative Buy.
It was a great day for beaten-down energy stocks.
Core Laboratories (NYSE:CLB) had declared $0.01/share quarterly dividend, in line with previous.Payable Aug. 29; for shareholders of record Aug. 8; ex-div Aug.
CLB earnings call for the period ending June 30, 2022.
Investors weren''t in a particularly forgiving mood after the company unveiled its latest set of quarterly earnings Wednesday night.
Core Laboratories N.V. (NYSE:NYSE:CLB) Q2 2022 Earnings Conference Call July 28, 2022, 8:30 am ET Company Participants Larry Bruno - Chairman & CEO Chris Hill - CFO Gwen Gresham - VP…
Core Laboratories (NYSE: CLB ) reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:00 PM. Here''s what investors need to know about the announcement. Earnings Core Laboratories missed estimated earnings by 7.69%, reporting an EPS of $0.12 versus an … Full story available on Benzinga.com
Core Laboratories Misses Q2 EPS by 2c
Core Laboratories (CLB): Q2 Non-GAAP EPS of $0.12 misses by $0.02.Revenue of $120.9M (+1.8% Y/Y) misses by $0.45M.Co sees Q3 revenue to range from $123M to $129M vs
SECOND QUARTER REVENUE OF $120.9 MILLION; UP 5% SEQUENTIALLY; UP 2% YEAR-OVER-YEAR SECOND QUARTER SEQUENTIAL INCREMENTAL MARGINS, EX-ITEMS, 43%, DRIVEN BY RESERVOIR DESCRIPTION SECOND QUARTER GAAP EPS OF $0.15; EPS, EX-ITEMS, $0.12 RENEWS AND EXTENDS REVOLVING CREDIT FACILITY THROUGH 2026…
https://www.investing.com/news/pro/core-laboratories-pt-lowered-to-20-at-stifel-432SI-2854235
These three energy-related names followed oil prices lower following the Fourth of July weekend.
Core Laboratories N.V. (NYSE:CLB) concluded the trading at $19.83 on Friday, July 01 with a rise of 0.10% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $19.81 and 5Y monthly beta was reading 2.79 with its price kept floating in the … Core Laboratories N.V. (CLB) Outlook: Revisiting The Past For Future Insights Read More »
Oil prices are down today, and oil stocks are following them down.
Harding Loevner, an investment management firm, published its “International Small Companies Equity Fund” first-quarter 2022 investor letter – a copy of which can be downloaded here.
A look at today''s fall and the underlying dynamics in the stock.
Core Laboratories N.V. (CLB) shares closed this week 20.4% lower than it did at the end of last week. The stock is currently down 3.0% year-to-date, down 52.0% over the past 12 months, and down 78.1% over the past five years. This week, the Dow Jones Industrial Average fell 7.2%, and the S&P 500 fell 8.7%. Trading Activity Shares traded as high as $27.12 and as low as $20.95 this week.Shares closed 54.6% below its 52-week high and 4.1% below its 52-week low.Trading volume this week was 27.2% higher than the 10-day average and 35.0% higher than the 30-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Industrials industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -114.6% The company's stock price performance over the past 12 months lags the peer average by 661.9% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 1724.8% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Core Laboratories N.V. (CLB) shares closed 4.1% lower than its previous 52 week low, giving the company a market cap of $1B. The stock is currently down 3.0% year-to-date, down 52.0% over the past 12 months, and down 78.1% over the past five years. This week, the Dow Jones Industrial Average fell 7.2%, and the S&P 500 fell 8.7%. Trading Activity Trading volume this week was 35.0% higher than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -114.6% The company's stock price performance over the past 12 months lags the peer average by 661.9% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 1724.8% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Few investors are happy when a company announces a new stock issue.
Core Laboratories (CLB) has launched a $60M at-the-market equity offering program.The company plans to sell its common shares having an aggregate sales price of up to $60M as part of…
The reservoir optimization company continues to have strong medium-term growth prospects.
Distillation Systems in Food and Beverage Application Market Market Comprehensive Study Explores Huge by 2027 Global Distillation Systems in Food and Beverage Application Market 2021 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing
Core Laboratories N.V. with ticker code (CLB) now have 10 analysts covering the stock. The analyst consensus points to a rating of ''Hold''. The range between the high target price and low target price is between 54 and 17 and has a mean target at 33.2. With the stocks previous close at 39.11 this would indicate that there is a downside of -15.1%. The 50 day moving average now sits at 41.92 while the 200 day moving average is 34.47. The company has a market cap of $1,795m. Company Website: /> [stock_market_widget type="chart" symbol="CLB" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients'' reservoirs.
This trio of energy names got a boost when a key commodity hit an equally key price level.
AMSTERDAM, June 29, 2021 /PRNewswire/ -- Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its second quarter 2021 conference call over the Internet at 7:30 a.m. CDT / 2:30 p.m.
Core Laboratories N.V. with ticker code (CLB) now have 11 analysts in total covering the stock. The consensus rating is ''Hold''. The range between the high target price and low target price is between 54 and 17 calculating the mean target price we have 32.73. Given that the stocks previous close was at 42.11 this now indicates there is a potential downside of -22.3%. The 50 day moving average now sits at 41.08 while the 200 day moving average is 34.06. The market capitalisation for the company is $1,825m. Company Website: /> [stock_market_widget type="chart" symbol="CLB" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients'' reservoirs.
The oilfield services stock has cooled off after a big run.
Van Eck Associates heeft een kleiner belang in Core Laboratories gemeld. Dit bleek uit een melding in het kader van de Wet op het financieel toezicht, gedateerd op 15 juni 2021.
→ Google Translate
Core Laboratories N.V. with ticker code (CLB) have now 11 analysts covering the stock. The analyst consensus points to a rating of ''Hold''. The target price ranges between 54 and 17 with a mean TP of 32.73. With the stocks previous close at 47.81 this now indicates there is a potential downside of -31.5%. The 50 day MA is 37.18 while the 200 day moving average is 32.74. The company has a market cap of $2,107m. You can visit the company''s website by visiting: /> [stock_market_widget type="chart" symbol="CLB" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients'' reservoirs.
Core Laboratories N.V. found using ticker (CLB) now have 11 analysts in total covering the stock. The consensus rating is ''Hold''. The range between the high target price and low target price is between 44 and 17 with a mean TP of 29.64. With the stocks previous close at 47.56 this would imply there is a potential downside of -37.7%. There is a 50 day moving average of 34.14 and the 200 moving average now moves to 31.9. The market cap for the company is $2,218m. Company Website: /> [stock_market_widget type="chart" symbol="CLB" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients'' reservoirs.
De AEX-index in Amsterdam is donderdag licht lager gesloten. Betalingsdienstverlener Adyen was, net als een dag eerder, opnieuw de grootste daler. De beurzen elders in Europa lieten wisselende uitslagen zien. Beleggers deden het rustig aan in afwachting van het officiële banencijfer van de Amerikaanse overheid dat vrijdag verschijnt. Donderdag kwamen al gegevens naar buiten die wijzen op verdere verbetering van de arbeidsmarkt in s werelds grootste economie.De AEX-index op Beursplein 5 eindigde 0,3 procent lager op 717,08 punten. De MidKap verloor 0,4 procent tot 1070,74 punten. Parijs en Londen leverden tot 0,6 procent in. De beurs in Frankfurt klom 0,3 procent.Adyen, dat donderdag zijn jaarvergadering hield, bungelde onderaan de hoofdindex met een min van 3,2 procent. Op woensdag daalde het aandeel al dik 2 procent. Prosus verloor 1,1 procent. De techinvesteerder neemt technologieplatform Stack Overflow over voor een bedrag van ongeveer 1,8 miljard dollar. Daarmee voegt het bedrijf nog een onlineleerplatform toe aan zijn toch al groeiende portfolio.
→ Google Translate
De Europese beurzen lieten donderdag overwegend kleine verliezen zien. Beleggers deden het rustig aan in afwachting van het banenrapport van de Amerikaanse loonstrookverwerker ADP. Dat rapport vormt een belangrijke indicator voor het officiële banencijfer van de Amerikaanse overheid, dat vrijdag verschijnt.Ook worden later op de dag de wekelijkse aanvragen voor werkloosheidsuitkeringen in de Verenigde Staten bekendgemaakt. De situatie op de Amerikaanse arbeidsmarkt is van belang voor beleggers aangezien de werkgelegenheid naast de inflatie een belangrijke rol speelt in het rentebeleid van de Federal Reserve.De AEX-index op Beursplein 5 noteerde rond het middaguur 0,2 procent lager op 717,70 punten. De MidKap verloor 0,3 procent tot 1071,73 punten. De beurzen in Frankfurt en Parijs daalden 0,1 procent. Een sterker dan verwachte toename van de economische bedrijvigheid in de eurozone in mei hield de koersverliezen beperkt. Londen zakte 0,7 procent.Staalfabrikant ArcelorMittal was de grootste daler in de AEX met een verlies van 1,2 procent.
→ Google Translate
De Amsterdamse AEX-index ging donderdag licht omlaag na het nieuwe slotrecord van een dag eerder. Beleggers namen weinig risico en keken vooral uit naar het banenrapport van de Amerikaanse loonstrookverwerker ADP. Dat rapport vormt een belangrijke indicator voor het officiële banencijfer van de Amerikaanse overheid, dat vrijdag op het programma staat.Ook worden later op de dag de wekelijkse aanvragen voor werkloosheidsuitkeringen in de Verenigde Staten bekendgemaakt. De situatie op Amerikaanse arbeidsmarkt is van belang aangezien de werkgelegenheid een belangrijke rol speelt in het rentebeleid van de Federal Reserve.De hoofdindex op Beursplein 5 noteerde in de ochtendhandel 0,2 procent in de min op 717,22 punten. De MidKap daalde ook 0,2 procent, tot 1072,95 punten. De graadmeters in Frankfurt, Londen en Parijs verloren tot 0,5 procent.Grootste daler in de AEX was Prosus met een verlies van 0,8 procent. De techinvesteerder neemt technologieplatform Stack Overflow over voor een bedrag van ongeveer 1,8 miljard dollar.
→ Google Translate
Core Laboratories N.V. with ticker code (CLB) have now 11 analysts in total covering the stock. The consensus rating is ''Hold''. The target price ranges between 44 and 17 with the average target price sitting at 29.64. Given that the stocks previous close was at 41.11 this is indicating there is a potential downside of -27.9%. There is a 50 day moving average of 31.93 and the 200 day moving average is 31.08. The company has a market capitalisation of $1,936m. Find out more information at: /> [stock_market_widget type="chart" symbol="CLB" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients'' reservoirs.
Core Laboratories N.V. (CLB) shares closed today at 0.4% below its 52 week high of $41.97, giving the company a market cap of $1B. The stock is currently up 57.8% year-to-date, up 109.7% over the past 12 months, and down 62.3% over the past five years. This week, the Dow Jones Industrial Average rose 1.1%, and the S&P 500 rose 1.2%. Trading Activity Trading volume this week was 13.8% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.7. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold.The stock closed at 5.4% higher than its 5-day moving average, 19.5% higher than its 20-day moving average, and 26.2% higher than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 52.7% The company's stock price performance over the past 12 months beats the peer average by 45.2% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -4660.2% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Core Laboratories N.V. with ticker code (CLB) now have 11 analysts in total covering the stock. The consensus rating is ''Hold''. The range between the high target price and low target price is between 44 and 17 with the average target price sitting at 29.64. Given that the stocks previous close was at 37.45 this would indicate that there is a downside of -20.9%. The 50 day MA is 30.29 and the 200 day MA is 30.26. The market cap for the company is $1,771m. Find out more information at: /> [stock_market_widget type="chart" symbol="CLB" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients'' reservoirs.
Core Laboratories N.V. with ticker code (CLB) have now 11 analysts covering the stock. The analyst consensus points to a rating of ''Hold''. The range between the high target price and low target price is between 44 and 17 with the average target price sitting at 29.64. Now with the previous closing price of 33.96 this now indicates there is a potential downside of -12.7%. The 50 day MA is 29.33 while the 200 day moving average is 29.49. The market cap for the company is $1,600m. Visit the company website at: /> [stock_market_widget type="chart" symbol="CLB" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients'' reservoirs.
Core Laboratories N.V. found using ticker (CLB) now have 11 analysts covering the stock. The analyst consensus points to a rating of ''Hold''. The range between the high target price and low target price is between 44 and 17 and has a mean target at 29.64. With the stocks previous close at 33.81 this indicates there is a potential downside of -12.3%. The day 50 moving average is 28.87 and the 200 day MA is 28.8. The market cap for the company is $1,528m. Visit the company website at: /> [stock_market_widget type="chart" symbol="CLB" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients'' reservoirs.
Evercore ISI Stick to Their Hold Rating for Core Laboratories N.V.
Shares of Core Laboratories (NYSE:CLB) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell …
AMSTERDAM, March 22, 2021 /PRNewswire/ -- Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its first quarter 2021 conference call over the Internet at 7:30 a.m. CDT / 2:30 p.m. CEST on April 22, 2021. Larry Bruno, Chairman, CEO and President, Chris Hill,…
Core Laboratories NV shares closed 0.5% lower than its previous 52 week high, giving the company a market cap of $1B. The stock is currently up 55.9% year-to-date, up 217.0% over the past 12 months, and down 60.2% over the past five years. This week, the Dow Jones Industrial Average rose 1.4%, and the S&P 500 rose 0.2%. Trading Activity Trading volume this week was 15.6% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 1.1% The company's stock price performance over the past 12 months beats the peer average by 42.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
AMSTERDAM, Jan. 27, 2021 /PRNewswire/ -- Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported that continuing operations resulted in fourth quarter 2020 revenue of $113,700,000. Core's operating income was $23,400,000,…
Core Laboratories announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
AMSTERDAM, Jan. 15, 2021 /PRNewswire/ -- The Board of Supervisory Directors of Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam Exchange: "CLB NA") has announced a cash dividend of $0.01 per share of common stock payable in the first quarter of 2021. This first quarter…
AMSTERDAM, Dec. 17, 2020 /PRNewswire/ -- Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core," "Core Lab," or the "Company") announced today that it has established an at-the-market equity offering program (the "ATM Program") under which it may, from time to…
Core Laboratories (NYSE:CLB) had its price target lowered by equities researchers at Smith Barney Citigroup from $21.00 to $16.00 in a report released on Friday, The Fly reports. Smith Barney Citigroup’s target price suggests a potential upside of 4.23% from the company’s previous close. CLB has been the subject of several other research reports. Morgan […]
Core Laboratories (NYSE:CLB) announced its quarterly earnings results on Wednesday. The oil and gas company reported $0.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.14 by $0.02, MarketWatch Earnings reports. Core Laboratories had a positive return on equity of 46.27% and a negative net margin of 13.39%. The company had […]
Wall Street analysts expect Core Laboratories (NYSE:CLB) to post earnings per share (EPS) of $0.13 for the current fiscal quarter, Zacks reports. Three analysts have issued estimates for Core Laboratories’ earnings, with the lowest EPS estimate coming in at $0.08 and the highest estimate coming in at $0.21. Core Laboratories posted earnings per share of […]